Random Start Ovarian Stimulation

Fertility preservation is emerging in recent years as an important option for various indications many of which being for cancer patients and for certain benign conditions as well. In the present case report, we set out to utilise the same protocol, however, for different indications.

[1]  A. Chien,et al.  Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer , 2017, Human reproduction.

[2]  S. Giordano,et al.  Impact of delayed neoadjuvant systemic chemotherapy on survival outcomes in breast cancer patients. , 2016 .

[3]  H. Cai,et al.  Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  E. Capp,et al.  Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[5]  N. Deshpande,et al.  Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review , 2015, Cancer.

[6]  M. Rosen,et al.  Random-start ovarian stimulation in patients with cancer , 2015, Current opinion in obstetrics & gynecology.

[7]  G. Hortobagyi,et al.  Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. de Ziegler,et al.  Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study. , 2013, Human reproduction.

[9]  N. Topham,et al.  Preoperative delays in the US Medicare population with breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Cedars,et al.  Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. , 2012, Fertility and sterility.

[11]  C. McCulloch,et al.  Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer , 2012, Cancer.

[12]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  K. Oktay,et al.  Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. , 2011, Fertility and sterility.

[14]  G. Bedoschi,et al.  Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature , 2010, Journal of Assisted Reproduction and Genetics.

[15]  I. Wapnir,et al.  Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. , 2009, Journal of the American College of Surgeons.

[16]  T. Strowitzki,et al.  Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. , 2009, Fertility and sterility.

[17]  E. Winer,et al.  Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. , 2007, European journal of cancer.

[18]  R. Elledge,et al.  The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane , 2007, American journal of clinical oncology.

[19]  E. Kolibianakis,et al.  GnRH antagonists in ovarian stimulation for IVF. , 2006, Human reproduction update.

[20]  R. Pierson,et al.  Characterization of Ovarian Follicular Wave Dynamics in Women1 , 2003, Biology of reproduction.

[21]  B. Hédon,et al.  Successful in vitro fertilization-surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy and pelvic irradiation. , 2001, Fertility and sterility.

[22]  D. Baird,et al.  Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. , 1999, Human reproduction.

[23]  M. Cobleigh,et al.  Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  I. Craft,et al.  Experience with gestational surrogacy as a treatment for sterility resulting from hysterectomy. , 1997, Human reproduction.